@BianchiniGP
Giampaolo Bianchini
3 years
📢TNBC micro-environment Source of heterogeneity: 1) amount of cells (e.g sTILs) 2) type of cells (e.g CD8, CD4, B cell) 3) functional status of cells (e.g M1 vs M2) 4)❗️spatial distribution of cells❗️ Next step: integration of all these 4 features in a TNBC ecosystem landscape
@StoverLab
Daniel Stover, MD, FASCO
3 years
The #TNBC immune microenvironment is not just ‘hot’ or ‘cold’ - distinct excluded, ignored and inflamed phenotypes w distinct ICI responses. Spatial profiling is coming! @NatureComms #bcsm @OncoAlert
1
38
130
2
17
57

Replies

@shycollie
Shycollie
3 years
@BianchiniGP @OncoAlert From a practical standpoint, now that we use immunotherapy neo-adjuvantly, it would be nice if we could get some NCCN flexibility for folks with ER of 5 percent or so—ER poor but not technically zero. Insurances won’t cover IO in these ladies, maybe they shouldn’t? But still…
1
0
1
@drtimrobinson
Tim Robinson
3 years
@BianchiniGP And importantly how our treatments, including chemo/ADC/ICI, may alter them
0
0
1